While much of the understanding of EWSR1/EWS centres around the chromosomal translocation that causes sarcoma, naturally occurring variants and transgenic mice indicate the diverse roles played this molecule (and closely related genes FUS and TAF15) and highlight challenges for therapeutic targeting in sarcoma. This evidence concerns the gene FUS and sarcoma.